Concepedia

Author

Rhoda Arzoomanian

University of Wisconsin–Madison

Also Known As

R Arzoomanian, R Z Arzoomanian, Rhoda Arzoomanian, Rhoda Z Arzoomanian, Rhoda Z. Arzoomanian

29

Publications

1.2K

Citations

15

H-Index

33

Concepts

All Affiliations

University of Wisconsin–MadisonSpanish Oncology Genitourinary GroupUniversity of Wisconsin Carbone Cancer CenterUniversity of Wisconsin System
RA

About

Rhoda Arzoomanian is an author at University of Wisconsin–Madison specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

594

2

Pharmacology

11

11

594

3

Health Sciences

2

2

222

4

Pathology

2

2

150

5

Alcohol-related Liver Disease

2

2

222

Rhoda Arzoomanian

×

17

Publications

1.1K

Citations

15

H-Index

YearCitations

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

James P. Thomas, Rhoda Arzoomanian, Dona Alberti,

Journal of Clinical Oncology

2003

226

A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer

Lynn Van Ummersen, Kim Binger, Jennifer Volkman,

Clinical Cancer Research

2004

157

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol

James P. Thomas, Kendra D. Tutsch, James F. Cleary,

Cancer Chemotherapy and Pharmacology

2002

122

Phase I clinical trial of perillyl alcohol administered daily.

Gregory H. Ripple, Michael N. Gould, James A. Stewart,

PubMed

1998

116

Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

Gregory H. Ripple, Michael N. Gould, Rhoda Arzoomanian,

PubMed

2000

106

Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer.

Glenn Liu, George Wilding, Mary Jane Staab,

PubMed

2003

70

Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.

Glenn Liu, Kurt R. Oettel, Gregory H. Ripple,

PubMed

2002

65

Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer

Glenn Liu, Kurt R. Oettel, Howard H. Bailey,

Investigational New Drugs

2003

58

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors

Jordan Berlin, Dona Alberti, Rhoda Arzoomanian,

Investigational New Drugs

1998

34

Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor

Joan H. Schiller, Patricia L. Witt, Barry Storer,

Cancer

1992

29

Page 1